{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:39:26Z","timestamp":1779100766235,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,10,29]],"date-time":"2003-10-29T00:00:00Z","timestamp":1067385600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/1471-244x-3-15","type":"journal-article","created":{"date-parts":[[2003,11,25]],"date-time":"2003-11-25T07:19:29Z","timestamp":1069744769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["The Renin-Angiotensin-Aldosterone system in patients with depression compared to controls \u2013 a sleep endocrine study"],"prefix":"10.1186","volume":"3","author":[{"given":"Harald","family":"Murck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Held","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Ziegenbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"K\u00fcnzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Steiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,10,29]]},"reference":[{"key":"33_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1017\/S0033291700013775","volume":"6","author":"BJ Carroll","year":"1976","unstructured":"Carroll BJ, Curtis GC, Mendels J: Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol Med. 1976, 6: 235-244.","journal-title":"Psychol Med"},{"key":"33_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1600-0447.1998.tb10092.x","volume":"98","author":"M Maes","year":"1998","unstructured":"Maes M, Lin A, Bonaccorso S, van Hunsel F, Van Gastel A, Delmeire L, Biondi M, Bosmans E, Kenis G, Scharpe S: Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr Scand. 1998, 98: 328-35.","journal-title":"Acta Psychiatr Scand"},{"key":"33_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0165-0327(89)90073-6","volume":"16","author":"A Steiger","year":"1989","unstructured":"Steiger A, von Bardeleben U, Herth T, Holsboer F: Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. J Affect Disord. 1989, 16: 189-195. 10.1016\/0165-0327(89)90073-6.","journal-title":"J Affect Disord"},{"key":"33_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0165-0327(88)90081-X","volume":"15","author":"RC Casper","year":"1988","unstructured":"Casper RC, Kocsis J, Dysken M, Stokes P, Croughan J, Maas J: Cortisol measures in primary major depressive disorder with hypersomnia or appetite increase. J Affect Disord. 1988, 15: 131-140. 10.1016\/0165-0327(88)90081-X.","journal-title":"J Affect Disord"},{"key":"33_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0165-0327(89)90070-0","volume":"16","author":"MJ Garvey","year":"1989","unstructured":"Garvey MJ, Schaffer C, Schaffer L, Perry PJ: Is DST status associated with depression characteristics?. J Affect Disord. 1989, 16: 159-165. 10.1016\/0165-0327(89)90070-0.","journal-title":"J Affect Disord"},{"key":"33_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0165-0327(86)90006-6","volume":"10","author":"M Maes","year":"1986","unstructured":"Maes M, De Ruyter M, Hobin P, Suy E: The dexamethasone suppression test, the Hamilton Depression Rating Scale and the DSM-III depression categories. J Affect Disord. 1986, 10: 207-214. 10.1016\/0165-0327(86)90006-6.","journal-title":"J Affect Disord"},{"key":"33_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0165-0327(88)90044-4","volume":"14","author":"A Roy","year":"1988","unstructured":"Roy A: Cortisol nonsuppression in depression: relationship to clinical variables. J Affect Disord. 1988, 14: 265-270. 10.1016\/0165-0327(88)90044-4.","journal-title":"J Affect Disord"},{"key":"33_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1176\/ajp.146.3.329","volume":"146","author":"ME Thase","year":"1989","unstructured":"Thase ME, Himmelhoch JM, Mallinger AG, Jarrett DB, Kupfer DJ: Sleep EEG and DST findings in anergic bipolar depression. Am JPsychiatry. 1989, 146: 329-333.","journal-title":"Am JPsychiatry"},{"key":"33_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0306-4530(02)00031-8","volume":"28","author":"IA Antonijevic","year":"2003","unstructured":"Antonijevic IA, Murck H, Frieboes RM, Uhr M, Steiger A: On the role of menopause for sleep-endocrine alterations associated with major depression. Psychoneuroendocrinology. 2003, 28: 401-18. 10.1016\/S0306-4530(02)00031-8.","journal-title":"Psychoneuroendocrinology"},{"key":"33_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1210\/er.19.3.269","volume":"19","author":"ER De Kloet","year":"1998","unstructured":"De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M: Brain corticosteroid receptor balance in health and disease. Endocr Rev. 1998, 19: 269-301. 10.1210\/er.19.3.269.","journal-title":"Endocr Rev"},{"key":"33_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0306-4530(00)00006-8","volume":"25","author":"I Heuser","year":"2000","unstructured":"Heuser I, Deuschle M, Weber B, Stalla GK, Holsboer F: Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone. Psychoneuroendocrinology. 2000, 25: 513-518. 10.1016\/S0306-4530(00)00006-8.","journal-title":"Psychoneuroendocrinology"},{"key":"33_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1001\/archpsyc.60.1.24","volume":"60","author":"EA Young","year":"2003","unstructured":"Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H: Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry. 2003, 60: 24-8.","journal-title":"Arch Gen Psychiatry"},{"key":"33_CR13","first-page":"1361","volume":"7","author":"JA Whitworth","year":"1985","unstructured":"Whitworth JA, Butty J, Saines D, Scoggins B, Thatcher R: The effects of ACTH on the renin-aldosterone system in normotensive man. Clin Exp Hypertens A. 1985, 7: 1361-1376.","journal-title":"Clin Exp Hypertens A"},{"key":"33_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000054384","volume":"68","author":"M Deuschle","year":"1998","unstructured":"Deuschle M, Weber B, Colla M, Muller M, Kniest A, Heuser I: Mineralocorticoid receptor also modulates basal activity of hypothalamus-pituitary-adrenocortical system in humans. Neuroendocrinology. 1998, 68: 355-360. 10.1159\/000054384.","journal-title":"Neuroendocrinology"},{"key":"33_CR15","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1210\/jc.83.9.3339","volume":"83","author":"EA Young","year":"1998","unstructured":"Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H: The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans. J Clin Endocrinol Metab. 1998, 83: 3339-45. 10.1210\/jc.83.9.3339.","journal-title":"J Clin Endocrinol Metab"},{"key":"33_CR16","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1210\/jc.82.4.1106","volume":"82","author":"J Born","year":"1997","unstructured":"Born J, Steinbach D, Dodt C, Fehm HL: Blocking of central nervous mineralocorticoid receptors counteracts inhibition of pituitary-adrenal activity in human sleep. J Clin Endocrinol Metab. 1997, 82: 1106-1110. 10.1210\/jc.82.4.1106.","journal-title":"J Clin Endocrinol Metab"},{"key":"33_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0022-3956(93)90038-4","volume":"27","author":"A Steiger","year":"1993","unstructured":"Steiger A, Rupprecht R, Spengler D, Guldner J, Hemmeter , Rothe B, Damm K, Holsboer F.: Functional properties of deoxycorticosterone and spironolactone: molecular characterization and effects on sleep-endocrine activity. J Psychiatr Res. 1993, 27: 275-284. 10.1016\/0022-3956(93)90038-4.","journal-title":"J Psychiatr Res"},{"key":"33_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1046\/j.1365-2826.1998.00182.x","volume":"10","author":"D Jezova","year":"1998","unstructured":"Jezova D, Ochedalski T, Kiss A, Aguilera G: Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. J Neuroendocrinol. 1998, 10: 67-72. 10.1046\/j.1365-2826.1998.00182.x.","journal-title":"J Neuroendocrinol"},{"key":"33_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1006\/frne.1993.1008","volume":"14","author":"WF Ganong","year":"1993","unstructured":"Ganong WF: Blood, pituitary, and brain renin-angiotensin systems and regulation of secretion of anterior pituitary gland. Front Neuroendocrinol. 1993, 14: 233-249. 10.1006\/frne.1993.1008.","journal-title":"Front Neuroendocrinol"},{"key":"33_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0304-3940(02)00527-X","volume":"328","author":"TC Baghai","year":"2002","unstructured":"Baghai TC, Sch\u00fcle C, Zwanzger P, Minov C, Zill P, Ella R, Eser D, Oezer S, Bondy B, Rupprecht R: Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene. Neurosci Lett. 2002, 328: 299-303. 10.1016\/S0304-3940(02)00527-X.","journal-title":"Neurosci Lett"},{"key":"33_CR21","first-page":"E43","volume":"276","author":"A Charloux","year":"1999","unstructured":"Charloux A, Gronfier C, Lonsdorfer-Wolf E, Piquard F, Brandenberger G: Aldosterone release during the sleep-wake cycle in humans. Am J Physiol. 1999, 276: E43-E49.","journal-title":"Am J Physiol"},{"key":"33_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2869.1992.tb00042.x","volume":"1","author":"W Van den Burg","year":"1992","unstructured":"Van den Burg W, Beersma DG, Bouhuys AL, Van den Hoofdakker RH: Self-rated arousal concurrent with the antidepressant response to total sleep deprivation of patients with a major depressive disorder: a disinhibition hypothesis. J Sleep Res. 1992, 1: 211-222.","journal-title":"J Sleep Res"},{"key":"33_CR23","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1192\/bjp.111.481.1133","volume":"111","author":"A Coppen","year":"1965","unstructured":"Coppen A: Mineral metabolism in affective disorders. Br J Psychiatry. 1965, 111: 1133-1142.","journal-title":"Br J Psychiatry"},{"key":"33_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1600-0447.1986.tb02705.x","volume":"73","author":"RT Joffe","year":"1986","unstructured":"Joffe RT, Blank DW, Berrettini WH, Post RM: Erythrocyte sodium and potassium in affective illness. Acta Psychiatr Scand. 1986, 73: 416-419.","journal-title":"Acta Psychiatr Scand"},{"key":"33_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000118914","volume":"26","author":"J Widmer","year":"1992","unstructured":"Widmer J, Bovier P, Karege F, Raffin Y, Hilleret H, Gaillard JM, Tissot R: Evolution of blood magnesium, sodium and potassium in depressed patients followed for three months. Neuropsychobiology. 1992, 26: 173-179.","journal-title":"Neuropsychobiology"},{"key":"33_CR26","first-page":"33","volume":"6","author":"J Widmer","year":"1993","unstructured":"Widmer J, Stella N, Raffin Y, Bovier P, Gaillard JM, Hilleret H, Tissot R: Blood magnesium, potassium, sodium, calcium and cortisol in drug-free depressed patients. Magnes Res. 1993, 6: 33-41.","journal-title":"Magnes Res"},{"key":"33_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0165-0327(95)00018-I","volume":"34","author":"J Widmer","year":"1995","unstructured":"Widmer J, Henrotte JG, Raffin Y, Bovier P, Hilleret H, Gaillard JM: Relationship between erythrocyte magnesium, plasma electrolytes and cortisol, and intensity of symptoms in major depressed patients. J Affect Disord. 1995, 34: 201-209. 10.1016\/0165-0327(95)00018-I.","journal-title":"J Affect Disord"},{"key":"33_CR28","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1210\/jcem-22-12-1187","volume":"22","author":"R Horton","year":"1962","unstructured":"Horton R, Biglieri EG: Effect of Aldosterone on the Metabolism of Magnesium. J Clin Endocrinol Metab. 1962, 22: 1187-1192.","journal-title":"J Clin Endocrinol Metab"},{"key":"33_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1113\/expphysiol.1989.sp003275","volume":"74","author":"JA Charlton","year":"1989","unstructured":"Charlton JA, Armstrong DG: The effect of an intravenous infusion of aldosterone upon magnesium metabolism in the sheep. Q J Exp Physiol. 1989, 74: 329-337.","journal-title":"Q J Exp Physiol"},{"key":"33_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF00429057","volume":"45","author":"AC Altamura","year":"1975","unstructured":"Altamura AC, Morganti A: Plasma renin activity in depressed patients treated with increasing doses of lithium carbonate. Psychopharmacologia. 1975, 45: 171-5.","journal-title":"Psychopharmacologia"},{"key":"33_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1192\/bjp.131.6.575","volume":"131","author":"RP Hullin","year":"1977","unstructured":"Hullin RP, Jerram TC, Lee MR, Levell MJ, Tyrer SP: Renin and aldosterone relationships in manic depressive psychosis. Br J Psychiatry. 1977, 131: 575-81.","journal-title":"Br J Psychiatry"},{"key":"33_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0306-4530(82)90008-7","volume":"7","author":"F Holsboer","year":"1982","unstructured":"Holsboer F, Dorr HG, Sippell WG: Blunted aldosterone response to dexamethasone in female patients with endogenous depression. Psychoneuroendocrinology. 1982, 7: 155-162. 10.1016\/0306-4530(82)90008-7.","journal-title":"Psychoneuroendocrinology"},{"key":"33_CR33","first-page":"5","volume":"3","author":"IA Antonijevic","year":"2000","unstructured":"Antonijevic IA, Murck H, Frieboes RM, Barthelmes J, Steiger A: Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls \u2013 part I: the sleep EEG. Sleep Research Online. 2000, 3: 5-13.","journal-title":"Sleep Research Online"},{"key":"33_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0022-3956(91)90021-2","volume":"25","author":"A Steiger","year":"1991","unstructured":"Steiger A, von Bardeleben U, Wiedemann K, Holsboer F: Sleep EEG and nocturnal secretion of testosterone and cortisol in patients with major endogenous depression during acute phase and after remission. J Psychiatr Res. 1991, 25: 169-177. 10.1016\/0022-3956(91)90021-2.","journal-title":"J Psychiatr Res"},{"key":"33_CR35","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/S0006-3223(96)00259-4","volume":"41","author":"ME Thase","year":"1997","unstructured":"Thase ME, Kupfer DJ, Fasiczka AJ, Buysse DJ, Simons AD, Frank E: Identifying an abnormal electroencephalographic sleep profile to characterize major depressive disorder. Biol Psychiatry. 1997, 41: 964-973. 10.1016\/S0006-3223(96)00259-4.","journal-title":"Biol Psychiatry"},{"key":"33_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1365-2869.1994.tb00101.x","volume":"3","author":"G Brandenberger","year":"1994","unstructured":"Brandenberger G, Charifi C, Muzet A, Saini J, Simon C, Follenius M: Renin as a biological marker of the NREM-REM sleep cycle: effect of REM sleep suppression. J Sleep Res. 1994, 3: 30-35.","journal-title":"J Sleep Res"},{"key":"33_CR37","first-page":"E43","volume":"276","author":"A Charloux","year":"1999","unstructured":"Charloux A, Gronfier C, Lonsdorfer-Wolf E, Piquard F, Brandenberger G: Aldosterone release during the sleep-wake cycle in humans. Am J Physiol. 1999, 276: E43-E49.","journal-title":"Am J Physiol"},{"key":"33_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1055\/s-2002-33195","volume":"35","author":"K Held","year":"2002","unstructured":"Held K, Antonijevic IA, K\u00fcnzel H, Uhr M, Wetter TC, Golly IC, Steiger A, Murck H.: Oral Mg 2+ supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry. 2002, 35: 135-143. 10.1055\/s-2002-33195.","journal-title":"Pharmacopsychiatry"},{"key":"33_CR39","volume-title":"A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects.","author":"A Rechtschaffen","year":"1968","unstructured":"Rechtschaffen A, Kales A: A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. 1968, US Department of Health, Education & Welfare, Neurological Information Network Bethesda, MD"},{"key":"33_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0306-4530(82)90008-7","volume":"7","author":"F Holsboer","year":"1982","unstructured":"Holsboer F, Dorr HG, Sippell WG: Blunted aldosterone response to dexamethasone in female patients with endogenous depression. Psychoneuroendocrinology. 1982, 7: 155-162. 10.1016\/0306-4530(82)90008-7.","journal-title":"Psychoneuroendocrinology"},{"key":"33_CR41","first-page":"871","volume":"262","author":"WV Vieweg","year":"1992","unstructured":"Vieweg WV, Veldhuis JD, Carey RM: Temporal pattern of renin and aldosterone secretion in men: effects of sodium balance. Am J Physiol. 1992, 262: 871-877.","journal-title":"Am J Physiol"},{"key":"33_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0165-1781(00)00178-5","volume":"95","author":"R Armitage","year":"2000","unstructured":"Armitage R, Hoffmann R, Trivedi M, Rush AJ: Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls. Psychiatry Res. 2000, 95: 201-213. 10.1016\/S0165-1781(00)00178-5.","journal-title":"Psychiatry Res"},{"key":"33_CR43","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/0006-3223(91)90355-P","volume":"29","author":"C Lauer","year":"1991","unstructured":"Lauer C, Riemann D, Wiegand M, Berger M: From early to late adulthood. Changes in EEG sleep of depressed patients and healthy volunteers. Biol Psychiatry. 1991, 29: 979-993. 10.1016\/0006-3223(91)90355-P.","journal-title":"Biol Psychiatry"},{"key":"33_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1034\/j.1601-5215.2003.00029.x","volume":"15","author":"H Murck","year":"2003","unstructured":"Murck H: Atypical depression spectrum disorder \u2013 neurobiology and treatment. Acta Neuropsych. 2003, 15: 227-241. 10.1034\/j.1601-5215.2003.00029.x.","journal-title":"Acta Neuropsych"},{"key":"33_CR45","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000054487","volume":"70","author":"IA Antonijevic","year":"1999","unstructured":"Antonijevic IA, Murck H, Frieboes RM, Holsboer F, Steiger A: On the gender differences in sleep-endocrine regulation in young normal humans. Neuroendocrinology. 1999, 70: 280-287. 10.1159\/000054487.","journal-title":"Neuroendocrinology"},{"key":"33_CR46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0024-3205(03)00294-7","volume":"73","author":"MJ Garcia","year":"2003","unstructured":"Garcia MJ, Martinez-Martos JM, Mayas MD, Carrera MP, Ramirez-Exposito MJ: Hormonal status modifies renin-angiotensin system-regulating aminopeptidases and vasopressin-degrading activity in the hypothalamus-pituitary-adrenal axis of male mice. Life Sci. 2003, 73: 525-538. 10.1016\/S0024-3205(03)00294-7.","journal-title":"Life Sci"},{"key":"33_CR47","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s004240050379","volume":"434","author":"K Shricker","year":"1997","unstructured":"Shricker K, Holmer S, Kramer BK, Riegger GA, Kurtz A: The role of angiotensin II in the feedback control of renin gene expression. Pfl\u00fcgers Arch. 1997, 434: 166-172. 10.1007\/s004240050379.","journal-title":"Pfl\u00fcgers Arch"},{"key":"33_CR48","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/1028415021000039194","volume":"5","author":"H Murck","year":"2002","unstructured":"Murck H: Magnesium and affective disorders. Nutr Neurosci. 2002, 5: 375-89. 10.1080\/1028415021000039194.","journal-title":"Nutr Neurosci"},{"key":"33_CR49","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1097\/00004872-198909007-00005","volume":"7","author":"A Stella","year":"1989","unstructured":"Stella A, Macchi A, Genovesi S, Centonza L, Zanchetti A: Angiotensin converting enzyme inhibition and renin release from the kidney. J Hypertens Suppl. 1989, 7: S21-S25.","journal-title":"J Hypertens Suppl"},{"key":"33_CR50","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/978-1-4615-4871-3_41","volume":"449","author":"E Grazzini","year":"1998","unstructured":"Grazzini E, Boccara G, Joubert D, Trueba M, Durroux T, Guillon G, Gallo-Payet N, Chouinard L, Payet MD, Serradeil Le Gal C: Vasopressin regulates adrenal functions by acting through different vasopressin receptor subtypes. Adv Exp Med Biol. 1998, 449: 325-334.","journal-title":"Adv Exp Med Biol"},{"key":"33_CR51","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.npp.1300040","volume":"28","author":"ME Keck","year":"2003","unstructured":"Keck ME, Welt T, M\u00fcller MB, Uhr M, Ohl F, Wigger A, Toschi N, Holsboer F, Landgraf R.: Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology. 2003, 28 : 235-243. 10.1038\/sj.npp.1300040.","journal-title":"Neuropsychopharmacology"},{"key":"33_CR52","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/01.HYP.31.2.575","volume":"31","author":"S Csukas","year":"1998","unstructured":"Csukas S, Hanke CJ, Rewolinski D, Campbell WB: Prostaglandin E2-induced aldosterone release is mediated by an EP2 receptor. Hypertension. 1998, 31: 575-581.","journal-title":"Hypertension"},{"key":"33_CR53","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0262-1746(83)90048-3","volume":"10","author":"J Lieb","year":"1983","unstructured":"Lieb J, Karmali R, Horrobin DF: Elevated levels of prostaglandin E2 and thromboxane B2 in depression. Prostaglandins Leukot Med. 1983, 10: 361-367.","journal-title":"Prostaglandins Leukot Med"},{"key":"33_CR54","unstructured":"Murck H, Song C, Horrobin DF, Uhr M: Ethyl-EPA and dexamethasone-resistance in therapy-refractory depression. Submitted"},{"key":"33_CR55","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/0014-2999(73)90232-X","volume":"21","author":"P Schmiedek","year":"1973","unstructured":"Schmiedek P, Sadee W, Baethmann A: Cerebral uptake of a 3 H-labelled spirolactone compound in the dog. Eur J Pharmacol. 1973, 21: 238-41. 10.1016\/0014-2999(73)90232-X.","journal-title":"Eur J Pharmacol"},{"key":"33_CR56","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1046\/j.1365-2826.2002.00836.x","volume":"14","author":"M Uhr","year":"2002","unstructured":"Uhr M, Holsboer F, M\u00fcller MB: Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. J Neuroendocrinol. 2002, 14: 753-9. 10.1046\/j.1365-2826.2002.00836.x.","journal-title":"J Neuroendocrinol"},{"key":"33_CR57","volume-title":"Neuropsychopharmacology","author":"MB M\u00fcller","year":"2003","unstructured":"M\u00fcller MB, Keck ME, Binder EB, Kresse AE, Hagemeyer TP, Landgraf R, Holsboer F, Uhr M.: ABCB1 (MDR1)-Type P-Glycoproteins at the Blood-Brain Barrier Modulate the Activity of the Hypothalamic-Pituitary-Adrenocortical System: Implications for Affective Disorder. Neuropsychopharmacology. 2003, doi:101038\/sj.npp.1300257"},{"key":"33_CR58","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/sj.bjp.0704368","volume":"134","author":"CM Pariante","year":"2001","unstructured":"Pariante CM, Makoff A, Lovestone S, Feroli S, Heyden A, Miller AH, Kerwin RW: Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. Br J Pharmacol. 2001, 134: 1335-43.","journal-title":"Br J Pharmacol"},{"key":"33_CR59","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1152\/ajpcell.2000.278.6.C1256","volume":"278","author":"E Bello-Reuss","year":"2000","unstructured":"Bello-Reuss E, Ernest S, Holland OB, Hellmich MR: Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells. Am J Physiol Cell Physiol. 2000, 278: 1256-1265.","journal-title":"Am J Physiol Cell Physiol"},{"key":"33_CR60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1067\/mhj.2000.109976","volume":"140","author":"CB Nemeroff","year":"2000","unstructured":"Nemeroff CB, O'Connor CM: Introduction: Depression as a risk factor for cardiovascular and cerebrovascular disease: Emerging data and clinical perspectives. Am Heart J. 2000, 140: 55-56. 10.1067\/mhj.2000.109976.","journal-title":"Am Heart J"},{"key":"33_CR61","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/00006842-200203000-00010","volume":"64","author":"B Weber-Hamann","year":"2002","unstructured":"Weber-Hamann B, Hentschel F, Kniest A, Deuschle M, Colla M, Lederbogen F, Heuser I: Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom Med. 2002, 64: 274-277.","journal-title":"Psychosom Med"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-3-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-3-15\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-3-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-3-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:09:42Z","timestamp":1726240182000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-3-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,29]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,12]]}},"alternative-id":["33"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-3-15","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,29]]},"assertion":[{"value":"7 July 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"15"}}